First quarter 2019 results

Sanofi delivers strong Q1 2019 business EPS growth of 9.4% at CER

First quarter 2019 results were reviewed by management during a conference call with the financial community. The presentation was followed by a Q&A session.

• Recorded audio webcast
• Download the audio mp3 file
• Presentation
• Clinical trials appendix
• Press release
• Q1 2019 income statements
• Q1 2019 net sales by GBU, franchise, geographic region and product
• Download infographic
• Pre-quarterly results communication